Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia
DAISY
Retinal Biomarkers as a Tool for Early Detection of Endothelial Dysfunction in Women With Preeclampsia
1 other identifier
interventional
60
1 country
1
Brief Summary
Every pregnancy has a major impact on a woman's heart and blood vessels due to changes required by the body to maintain proper blood flow between mother and foetus. When the placenta does not work properly, preeclampsia can occur. An important first symptom is high blood pressure. Women who have experienced preeclampsia are at higher risk of developing blood pressure and heart problems later on. Therefore, it is very important to detect changes in the blood vessel system so that they can be treated promptly and correctly. We aim to do this by using a new, non-invasive eye test that examines the blood vessels of the retina.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedFirst Posted
Study publicly available on registry
July 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedJuly 24, 2025
July 1, 2025
5 months
July 1, 2025
July 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Retinal biomarkers
Early (retinal) biomarkers for cardiovascular risk in patients with preeclampsia, assessed by DVA.
Baseline
Study Arms (1)
Interventional group
OTHERAll patients in this study will undergo all vascular assessments including pulse wave velocity, pulse wave analysis, flow-mediated dilation, fundus photography and dynamic retinal vessel analysis.
Interventions
Non-invasive test. A blood pressure cuff and tonometer (a type of pen placed on the neck) are used to measure the speed at which a pressure wave propagates from one place to another. Every time the heart contracts, a pressure wave is generated that propagates from the heart to the blood vessels at a certain speed. The stiffer the blood vessels, the faster the wave propagates.
This study measures the capacity with which blood vessels expand when we briefly cut off blood flow. The endothelium, the inner layer of blood vessels, regulates this expansion. By ultrasound, we measure the difference in diameter of the elbow artery. To cut off the blood flow, we clamp the forearm with a blood pressure cuff for 5 minutes. When the blood pressure cuff is released, it triggers increased blood flow in the arm, causing the blood vessels to expand. We record this expansion using the above techniques.
Eye imaging measures the capacity with which your blood vessels in the retina can expand in response to a flicker light stimulation.
Eligibility Criteria
You may qualify if:
- at least 18 years old
- willing to undergo vascular assessments
- informed consent signed
You may not qualify if:
- Unwilling to provide informed consent
- Open-angle glaucoma
- Epilepsia
- (gestational) Diabetes
- Multiple pregnancies
- Fetal malformations
- Hypercholesterolemia
- Kidney disease
- Auto-immune disorders
- Connective tissue diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antwerp University Hospital
Edegem, Antwerp, 2650, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2025
First Posted
July 24, 2025
Study Start
July 1, 2025
Primary Completion
November 15, 2025
Study Completion
December 15, 2025
Last Updated
July 24, 2025
Record last verified: 2025-07